Afya Rekod vs CancerIQ

<p>Afya Rekod is a secure, blockchain-powered platform that enables you to take ownership of your health data by storing and managing your medical information with full control and privacy. It provides a universal patient portal that makes your health records accessible across multiple devices and supports sharing with healthcare providers to improve engagement and care. Whether you are a patient or a healthcare institution, Afya Rekod offers tools like dynamic electronic health records, disease management, remote patient monitoring, and AI-based health analysis to keep your information organized and actionable.</p> <p>With Afya Rekod, you gain access to a decentralized platform that bridges the gap between healthcare providers and patients, promoting better health outcomes and data mobility. The software abides by international security standards such as HIPAA and GDPR, ensuring your data stays safe and confidential. Additionally, their mobile apps and USSD access mean you can manage your health records from any device. This software suits individuals, medical practitioners, hospitals, and health institutions looking to streamline healthcare management with modern technology.</p>

<p>CancerIQ is a specialized healthcare management tool designed to enhance cancer genomics and oncology services within health systems. It enables you to perform cancer risk assessments, automate genetic counseling workflows, and engage patients with personalized educational resources. With integrated clinical decision support, it helps providers make evidence-based recommendations and manage care pathways efficiently.</p> <p>This platform benefits both providers and patients by improving screening, risk stratification, and adherence to medical management plans. CancerIQ supports workflow customization, EHR integration, and seamless genetic test ordering from multiple vendors. Its analytics track program performance and financial outcomes, making it a comprehensive solution for cancer risk and genetics programs across diverse clinical settings.</p>